Compared with IMN patients, IMN patients with FSGS had greater clinical manifestations of urinary protein, albumin, lipids, and blood creatinine at disease onset and a greater proportion of positive serum anti-PLA2R antibodies. Here, PLA2R1 is linked to focal segmental glomerulosclerosis.